Best iron supplement brand SEO Brief & AI Prompts

Feosol vs Slow Fe vs Niferex vs Feraheme vs Venofer pricing shows there is no single "best" iron supplement brand; the optimal choice depends on indication, tolerability, and cost-per-gram of elemental iron. Oral ferrous salts such as ferrous sulfate deliver about 65 mg elemental iron per 325 mg tablet, making generics lowest-cost per delivered iron for mild iron deficiency, while IV ferumoxytol (Feraheme) is labeled as two 510 mg IV doses for a 1,020 mg total and is reserved for patients with intolerance, malabsorption, or need for rapid repletion. Out-of-pocket costs vary widely by region.

Comparative pricing relies on converting product strength to elemental iron and calculating cost-per-gram using pharmacy pricing tools such as GoodRx and payer benchmarks like CMS Average Sales Price (ASP); the elementary calculation is elemental iron (mg) = tablet strength × percent elemental iron of the salt. For oral vs IV iron pricing comparisons clinicians and pharmacists should use the mg elemental basis rather than milligrams of the salt—ferrous sulfate, ferrous gluconate, and iron polysaccharide differ in percent elemental iron—and then add administration, monitoring, and billing costs for IV agents. WHO and specialty society guidelines inform when IV therapy is clinically indicated. Practices should also track acquisition costs, reimbursement codes, and local infusion capacity when modeling oral vs IV iron pricing.

A critical nuance is that retail price lists change rapidly and comparisons that omit source and date are misleading; retail figures should be cited (for example, GoodRx Jan 2026) and accompanied by payer-specific ASP or contract prices. Comparing tablet milligrams instead of converting to elemental iron leads to erroneous cost-per-iron calculations, and treating IV agents as interchangeable ignores differences in molecule and dosing: ferumoxytol pricing behaves differently from iron sucrose cost because ferumoxytol (Feraheme) is a superparamagnetic iron oxide colloid with distinct labeling, while Venofer (iron sucrose) requires multiple smaller infusions. For patients with intolerance or significant iron supplement side effects, higher IV acquisition and infusion costs—often hundreds to thousands—may be justified by faster repletion and improved adherence. Payer negotiation and outpatient clinic capacity materially alter realized costs significantly.

Practical application for clinicians and pharmacists is to calculate cost-per-gram-of-elemental-iron for each product, include administration and monitoring overhead for IV courses, and document price source and date (retail tools like GoodRx, hospital ASP, or payer contracts). Clinical decisions should weigh guideline-based indications (for example ACOG or WHO guidance), patient risk for iron supplement side effects, and operational factors such as infusion capacity. Comparative decisions that integrate these components will better identify when a low-cost oral agent is preferable versus when high-upfront IV investment is warranted. This page presents a structured, step-by-step framework for comparing brands and prices.